Download first ever cto crossing catheter real-time optical coherence

FIRST EVER
CTO C R O SS I N G C AT H E T E R
REAL-TIME
OPTICAL COHERENCE TOMOGRAPHY
PML 0017-E
CE MARKED. FDA CLEARED.
T H E O C E LOT SY S T E M I S I N T E N D E D TO FA C I L I TAT E
THE INTRALUMINAL PLACEMENT OF CONVENTIONAL
GUIDEWIRES BEYOND STENOTIC LESIONS (INCLUDING
S U B A N D C H R O N I C TOTA L O C C LU S I O N S ) I N T H E
P E R I P H E R A L VA S C U L AT U R E P R I O R TO F U R T H E R
P E R C U TA N E O U S I N T E R V E N T I O N U S I N G O CT - A SS I S T E D
O R I E N TAT I O N A S A N A D J U N C T T O F L U O R O S C O P Y.
T H E O C E LOT SY S T E M I S C O N T R A I N D I C AT E D FO R
USE IN THE ILIAC, CORONARY, CEREBRAL,
R E N A L O R C A R O T I D V A S C U L A T U R E . WARNING: NOT FOR DIAGNOSTIC USE.
PML 0017-E
FREEDOM FROM MAEs
98.0%
CROSSING SUCCESS
97.0%
NUMBER OF PATIENTS | 100
NUMBER OF SITES | 14
MEAN LESION LENGTH | 166mm
LESION LOCATION | SFA & POPLITEAL
PML 0017-E
KNOW WHERE YOU ARE.
DO SOMETHING ABOUT IT.
SEE: Using Ocelot’s real time, intravascular
imaging via optical coherence tomography, OCT.
NAVIGATE: Using Ocelot’s 3 marker system and
pre shaped tip to facilitate intravascular orientation.
CROSS: Using Ocelot’s unique spiral wedges to
corkscrew through the CTO.
PML 0017-E
N O N - L AY E R E D
STRUCTURES
MIDDLE
MARKER
L AY E R E D
STRUCTURES
OCELOT IMAGE TRANSLATION
MIDDLE MARKER: Opposite the deflection
of catheter tip.
LAYERED STRUCTURES: Indicates
intravascular arterial structures.
NON-LAYERED STRUCTURES: Indicates
intravascular atherosclerosis.
PML 0017-E
OCELOT SHOWS WHAT FLUORO DOES NOT
OCT | BRANCH SUPERIOR
FLUORO | BRANCH LATERAL
OCT | DEFLECTED TOWARD
LAYERED STRUCTURES
FLUORO | NOT HELPFUL FOR
CORRECT POSITIONING
OCT | ROTATION OF MIDDLE MARKER TO
CORRECT POSITION
FLUORO | NOT HELPFUL FOR
CORRECT POSITIONING
OCT | DEFLECTED TOWARD
NON-LAYERED STRUCTURES
FLUORO | NOT HELPFUL FOR
CORRECT POSITIONING
PML 0017-E
ATHERECTOMY
STENT
FOCUS ON YOUR TREATMENT
Post-crossing lumen allows for easy treatment of your choice.
POST-CTO CROSSING
TREATMENT TYPE AND PERCENT
CONNECT II
PRIMARY COHORT
(N=97)
TREATMENT TYPE
OCELOT POST-CROSSING LUMEN
ATHERECTOMY
53.6% ( 52 / 97 )
ANGIOPLASTY
94.8% ( 92 / 97 )
STENT
51.5% ( 50 / 97 )
OTHER
12.4% ( 12 / 97 )
ANGIOPLASTY
PML 0017-E
ONE LIGHTBOX.
A PIPELINE OF IMAGE
GUIDED PRODUCTS.
FDA CLEARED FOR PERIPHERAL CTOs
IN DEVELOPMENT FOR PERIPHERAL CTOs
IN DEVELOPMENT FOR PERIPHERAL ATHERECTOMY
PML 0017-E
E S T I M AT E D AVA I L A B I L I T Y
2012
2013
Q4
Q1
Q2
Q3
Q4
12
7
15
15
20
PML 0017-E
TECHNICAL SPECIFICATIONS
Product Catalogue Number:
O100
Crossing Profile:
2 mm (.080 inches)
Working Length:
110 cm (43.3 inches)
Sheath Compatibility:
6 French
Guidewire Compatibility:
.014 inches
PML 0017-E
TECHNICAL SPECIFICATIONS
Product Catalogue Number:
L100
Physician Display:
2560 x 1440 pixels
Operator Display:
1680 x 1050 pixels
Speed Control:
30, 45, 60 RPM
Data Storage Capacity:
100 hours video
OCT Technology:
Common Path
A reusable, dual display, mobile unit designed to deliver OCT images.
Lightbox is here to shed light on all our PAD procedures.
REAL TIME OCT
Receive continuous feedback to help guide crossing.
FLUORO SYNCHRONIZATION
Ability to correlate medial/lateral position on Lightbox with fluoroscopy.
MULTI-VIEW
View vessel morphology in both cross-sectional and waterfall views.
SPEED CONTROL
Manage tip rotation and imaging speed to 30, 45 or 60 RPM.
MEDIA CAPABILITIES
Image and movie capture, zoom, playback and export.
MOBILE
Position anywhere in the lab. Use in multiple labs.
PML 0017-E